BACKGROUND: The present study's aim was to examine the long-term effects (8 to 13 years post-treatment; M = 9.83 years; SD = 1.71) of the most widely used treatment approaches of exposure-based cognitive behavioral treatment for phobic and anxiety disorders in children and adolescents (i.e., group treatment and two variants of individual treatment). An additional aim was to compare the relative long-term efficacy of the treatment approaches. METHOD: At long-term follow-up, participants (N = 67) were between 16 and 26 years of age (M = 19.43 years, SD = 3.02). Primary outcome was the targeted anxiety disorder and targeted symptoms. Secondary outcomes were other disorders and symptoms not directly targeted in the treatments including (1) other anxiety disorders and symptoms, (2) depressive disorders and symptoms, and (3) substance use disorders and symptoms. RESULTS: Long-term remission for anxiety disorders and symptoms targeted in the treatments was evident 8 to 13 years post-treatment. Long-term remission also was found for the secondary outcomes. There were more similarities than differences in the long-term gains when comparing the treatment approaches. CONCLUSIONS: Consistent with past research, the study's findings provide further evidence that the short-term benefits of exposure-based CBT for childhood phobic and anxiety disorders using both group and individual treatment may extend into the critical transition years of young adulthood.
BACKGROUND: The present study's aim was to examine the long-term effects (8 to 13 years post-treatment; M = 9.83 years; SD = 1.71) of the most widely used treatment approaches of exposure-based cognitive behavioral treatment for phobic and anxiety disorders in children and adolescents (i.e., group treatment and two variants of individual treatment). An additional aim was to compare the relative long-term efficacy of the treatment approaches. METHOD: At long-term follow-up, participants (N = 67) were between 16 and 26 years of age (M = 19.43 years, SD = 3.02). Primary outcome was the targeted anxiety disorder and targeted symptoms. Secondary outcomes were other disorders and symptoms not directly targeted in the treatments including (1) other anxiety disorders and symptoms, (2) depressive disorders and symptoms, and (3) substance use disorders and symptoms. RESULTS: Long-term remission for anxiety disorders and symptoms targeted in the treatments was evident 8 to 13 years post-treatment. Long-term remission also was found for the secondary outcomes. There were more similarities than differences in the long-term gains when comparing the treatment approaches. CONCLUSIONS: Consistent with past research, the study's findings provide further evidence that the short-term benefits of exposure-based CBT for childhood phobic and anxiety disorders using both group and individual treatment may extend into the critical transition years of young adulthood.
Authors: John Piacentini; Shannon Bennett; Scott N Compton; Phillip C Kendall; Boris Birmaher; Anne Marie Albano; John March; Joel Sherrill; Dara Sakolsky; Golda Ginsburg; Moira Rynn; R Lindsey Bergman; Elizabeth Gosch; Bruce Waslick; Satish Iyengar; James McCracken; John Walkup Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-11-28 Impact factor: 8.829
Authors: Masha Y Ivanova; Thomas M Achenbach; Leslie A Rescorla; Lori V Tumer; Adelina Ahmeti-Pronaj; Alma Au; Carmen Avila Maese; Monica Bellina; J Carlos Caldas; Yi-Chuen Chen; Ladislav Csemy; Marina M da Rocha; Jeroen Decoster; Anca Dobrean; Lourdes Ezpeleta; Johnny R J Fontaine; Yasuko Funabiki; Halldór S Guðmundsson; Valerie S Harder; Marie Leiner de la Cabada; Patrick Leung; Jianghong Liu; Safia Mahr; Sergey Malykh; Jelena Srdanovic Maras; Jasminka Markovic; David M Ndetei; Kyung Ja Oh; Jean-Michel Petot; Geylan Riad; Direnc Sakarya; Virginia C Samaniego; Sandra Sebre; Mimoza Shahini; Edwiges Silvares; Roma Simulioniene; Elvisa Sokoli; Joel B Talcott; Natalia Vazquez; Ewa Zasepa Journal: J Psychopathol Behav Assess Date: 2014-08-08
Authors: Matti Cervin; Lesley A Norris; Golda Ginsburg; Elizabeth A Gosch; Scott N Compton; John Piacentini; Anne Marie Albano; Dara Sakolsky; Boris Birmaher; Courtney Keeton; Eric A Storch; Philip C Kendall Journal: J Am Acad Child Adolesc Psychiatry Date: 2020-09-17 Impact factor: 8.829